Overcoming PARPi resistance: Preclinical and clinical evidence in ovarian cancer

M Chiappa, F Guffanti, F Bertoni, I Colombo… - Drug Resistance …, 2021 - Elsevier
Ovarian cancer is the fifth cause of cancer-related deaths in women with high grade serous
carcinoma (HGSOC) representing the most common histological subtype. Approximately …

Expanding functions of ADP-ribosylation in the maintenance of genome integrity

K Martin-Hernandez, JM Rodriguez-Vargas… - Seminars in cell & …, 2017 - Elsevier
Cell response to genotoxic stress requires a complex network of sensors and effectors from
numerous signaling and repair pathways, among them the nuclear poly (ADP-ribose) …

Apoptotic vesicles are required to repair DNA damage and suppress premature cellular senescence

Z Huang, Y Zhuang, W Li, M Ma, F Lei… - Journal of …, 2024 - Wiley Online Library
It is well known that DNA damage can cause apoptosis. However, whether apoptosis and its
metabolites contribute to DNA repair is largely unknown. In this study, we found that …

Characterization of DNA ADP-ribosyltransferase activities of PARP2 and PARP3: new insights into DNA ADP-ribosylation

G Zarkovic, EA Belousova, I Talhaoui… - Nucleic acids …, 2018 - academic.oup.com
Abstract Poly (ADP-ribose) polymerases (PARPs) act as DNA break sensors and catalyze
the synthesis of polymers of ADP-ribose (PAR) covalently attached to acceptor proteins at …

The PARP inhibitor olaparib potentiates the effect of the DNA damaging agent doxorubicin in osteosarcoma

HJ Park, JS Bae, KM Kim, YJ Moon, SH Park… - Journal of Experimental …, 2018 - Springer
Background PARP1 facilitates the recovery of DNA-damaged cells by recruiting DNA
damage response molecules such as γH2AX and BRCA1/2, and plays a role in resistance to …

[HTML][HTML] Identification of differentially expressed genes between original breast cancer and xenograft using machine learning algorithms

D Wang, JR Li, YH Zhang, L Chen, T Huang, YD Cai - Genes, 2018 - mdpi.com
Breast cancer is one of the most common malignancies in women. Patient-derived tumor
xenograft (PDX) model is a cutting-edge approach for drug research on breast cancer …

The recent advances in non-homologous end-joining through the lens of lymphocyte development

XS Wang, BJ Lee, S Zha - DNA repair, 2020 - Elsevier
Lymphocyte development requires ordered assembly and subsequent modifications of the
antigen receptor genes through V (D) J recombination and Immunoglobulin class switch …

Structural basis for DNA break recognition by ARTD2/PARP2

E Obaji, T Haikarainen, L Lehtiö - Nucleic acids research, 2018 - academic.oup.com
Abstract Human ARTD2 (or PARP2) is an ADP-ribosyltransferase, which is catalytically
activated by binding to damaged DNA. ARTD2 subsequently ADP-ribosylates itself and …

[HTML][HTML] Therapeutic applications of PARP inhibitors in ovarian cancer

H **e, W Wang, B **a, W **, G Lou - Biomedicine & Pharmacotherapy, 2020 - Elsevier
Ovarian cancer is the most lethal gynecologic malignancy with a high recurrence rate. Poly
(ADP-ribose) polymerase inhibitors (PARPi) are one of the most active new therapies for …

Design, synthesis, and biological evaluation of a series of benzofuran [3, 2-d] pyrimidine-4 (3H)-one derivatives containing thiosemicarbazone analogs as novel PARP …

Y Wang, K Li, W Xu, S Gou - Bioorganic chemistry, 2023 - Elsevier
Poly ADP ribose polymerase-1 (PARP-1), one of the most important members of the PARP
protein family, plays a crucial role in DNA damage repair, gene transcription, and apoptosis …